Skip to content

Effect of Weight Loss Diet and Pumpkin Seed Flour Consumption on Obese Women

Effect of Hypoenergetic Diet Combined With Pumpkin Seed Flour Consumption on Obese Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02086396
Enrollment
139
Registered
2014-03-13
Start date
2011-10-31
Completion date
2013-09-30
Last updated
2014-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, cardiovascular risk factors, pumpkin seed, diet quality

Brief summary

This study aimed to evaluate the effect of weight loss diet combined with pumpkin seed flour consumption on diet improvement, weight loss, and glucose and cholesterol reduction in obese.

Interventions

DIETARY_SUPPLEMENTpumpkin seed flour

The pumpkin seed flour group received 20g/day of pumpkin seed flour during 12 weeks

The group placebo (cassava flour flavored) received 20g/day of cassava flour flavored during 12 weeks.

Sponsors

Rio de Janeiro State Research Supporting Foundation (FAPERJ)
CollaboratorOTHER_GOV
Universidade Federal do Rio de Janeiro
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 59 Years
Healthy volunteers
Yes

Inclusion criteria

* age from 20 to 59 years old. * body mass index above 30 kg/m2

Exclusion criteria

* diabetic * loss weight before the research * consumption of vitamins or dietary supplement. * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Anthropometric measuresChange from Baseline at 12 weeksbody weight (kg), body mass index (kg/m2), waist circumference (cm), neck circumference

Secondary

MeasureTime frameDescription
Blood lipidsChange from baseline at 12 weekstotal Cholesterol (mg/dl), LDL-cholesterol (mg/dl), HDL-cholesterol (mg/dl) and triglycerides (mg/dl)
Blood glucoseChange from baseline at 12 weeksglucose (mg/dL)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026